Business
Further Placing to raise £350,000
Further Placing to raise £350,000.
About this update from Truetide Plc
[{"type":"text","content":"\n \n \n RNS Number : 5793L\n Braveheart Investment Group plc\n 01 May 2020\n \n \n \n \n The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.\n \n \n 1 May 2020\n \n \n Braveheart Investment Group plc\n \n \n (\"Braveheart\" or \"the Company\")\n \n \n \n \n \n Further Placing to raise £350,000\n \n \n \n \n \n Braveheart Investment Group (AIM: BRH), is pleased to announce that, further to the announcement on 29 April 2020 and following significant demand from investors in the last two days, Peterhouse Capital Limited, the Company's broker acting as agent for the Company, has, in an over-subscribed placing placed a further 1,590,909 new ordinary shares of 2 pence each in the Company (\"Second Placing Shares\") at a price of 22 pence per share (\"Second Placing Price\") to raise £350,000, before expenses (the \"Second Placing\"). Investors have also been offered the opportunity to be issued with warrants. Pursuant to this offer, a total of 1,590,909 unlisted and non-transferable warrants in the Company, exercisable at 40 pence (\"Warrants\") within eighteen months from Second Admission (as defined below) may be issued to the acquirers of the Second Placing Shares. \n \n \n \n Placing highlights\n \n \n · \n The Company intends to primarily use the net proceeds of the Second Placing to enable the Company to continue to provide further additional financial investment into its Strategic Investments, as is required over the medium term, being: Paraytec Limited (100 per cent.), Pharm 2 Farm Limited (51.7 per cent.), Kirkstall Limited (64.67 per cent.), Gyrometric Systems Limited (19.95 per cent.), Phasefocus Holdings Limited (25.00 per cent.) and Sentinel Medical Limited (38.38 per cent.). The Board may consider adding new investments to its group of Strategic Investments but the priority will be the support of the existing Strategic Investments. \n \n \n · \n Following on from the placing announced on 29 April 2020, the Second Placing provides the Company with significant additional resources to assist its Strategic Investments to grow ...